Overview
ALMR market data
Price History
ALMR price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.45 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.12 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -40.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $18.85 – $38.54 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.9B.
Company News
Top 3 Health Care Stocks That May Implode In AugustBenzinga · Aug 12, 2026, 12:58 PM
Stifel Maintains Buy on Alamar Biosciences, Raises Price Target to $32Benzinga · Aug 11, 2026, 5:41 PM
Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming MomentumBenzinga · Aug 11, 2026, 5:25 PM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Aug 11, 2026, 5:06 PM
Alamar Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results. Also, JP Morgan maintained its Overweight rating on the stock and raised its price target from $32 to $35.Benzinga · Aug 11, 2026, 2:23 PM
JP Morgan Maintains Overweight on Alamar Biosciences, Raises Price Target to $35Benzinga · Aug 11, 2026, 2:09 PM
Quantum, Kopin, Alamar Biosciences And Other Big Stocks Moving Higher On TuesdayBenzinga · Aug 11, 2026, 2:08 PM
Alamar Biosciences Sees FY2026 Sales $116.000M-$120.000M vs $113.259M EstBenzinga · Aug 10, 2026, 8:42 PM
Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M EstimateBenzinga · Aug 10, 2026, 8:13 PM
8-K filing — Alamar Biosciences, Inc. (ALMR)SEC EDGAR · Aug 10, 2026, 8:10 PM